0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colorectal Cancer Screening & Diagnostic Market by Type (Screening Tests, Stool Tests), Product (Consumables, Instruments), Application, End User - Global Forecast 2025-2030- Product Image
Colorectal Cancer Screening & Diagnostic Market by Type (Screening Tests, Stool Tests), Product (Consumables, Instruments), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Colorectal Cancer Screening & Diagnostic Market by Type (Screening Tests, Stool Tests), Product (Consumables, Instruments), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925069
UP TO EUR$697USDGBP OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colorectal Cancer Screening & Diagnostic Market grew from USD 1.86 billion in 2024 to USD 1.99 billion in 2025. It is expected to continue growing at a CAGR of 7.41%, reaching USD 2.86 billion by 2030.

In the evolving domain of colorectal cancer screening and diagnostics, innovation has dramatically altered traditional pathways and established new benchmarks for early detection and monitoring. This report provides a comprehensive look into the current state and future potential of screening technologies, diagnostic protocols, and the integration of multi-dimensional data for improved patient care. With colorectal cancer remaining a critical health issue worldwide, the modernization of diagnostic methods underscores the importance of prompt and accurate testing. Current approaches harness advancements in both laboratory technology and imaging procedures to drive more effective and less invasive screening options. Trends in research and patient management have shifted from generic methodologies to highly personalized practices that can better predict disease trajectory and tailor individualized treatment plans. The transformative process is further amplified by emerging technologies in biomarker analysis, integration of computerized imaging, and innovative test kits that are reshaping the economic and clinical landscape. This introduction sets the stage for an in-depth exploration of how clinical innovation, technological breakthroughs, and strategic market segmentation are converging to redefine the future of colorectal cancer diagnostics. As we delve further, you will gain a clearer understanding of the multifaceted changes steering the industry and the actionable insights that can empower stakeholders within this crucial sector.

Transformative Shifts Reshaping the Colorectal Cancer Diagnostic Landscape

The landscape of colorectal cancer diagnostics has witnessed transformative shifts driven by rapid technological advancement and evolving healthcare priorities. These shifts are characterized by enhanced diagnostic precision, improved patient outcomes, and a growing reliance on artificial intelligence and digital imaging technology. Traditional screening methods are now being complemented by highly advanced systems that leverage innovative biomarker detection and real-time imaging, enabling earlier detection and more accurate prognosis assessments. Furthermore, there has been a significant move towards decentralizing testing facilities, with emerging models supporting ambulatory surgical centers and mobile diagnostic units that expand accessibility to underserved regions. Regulatory frameworks have simultaneously evolved, encouraging faster adoption of diagnostic innovations while ensuring compliance with stringent quality standards. This dynamic environment has spurred investments in research and development, leading to breakthroughs in non-invasive stool tests and cutting-edge imaging protocols. The integration of data analytics with diagnostic imaging has also paved the way for predictive diagnostics, whereby screening outcomes can guide personalized treatment regimens. Collectively, these transformative trends not only shorten diagnostic timelines but also enhance the overall accuracy of patient monitoring and disease management. Such progress is instrumental in shifting the competitive framework, paving the way for new market entrants and collaborations that further drive innovation and growth across the diagnostic spectrum.

Comprehensive Segmentation Insights in Screening Tests, Product, Application, and End User

An insightful examination of segmentation in the colorectal cancer screening and diagnostic market reveals a multi-layered structure that can be analyzed from several dimensions. First, when viewed by type, the market is meticulously divided between screening tests and stool tests. Within the screening tests category, advanced methodologies are split into blood tests and imaging tests, with imaging tests further scrutinized to reflect the nuances of colonoscopy, CT colonography, and flexible sigmoidoscopy. On the other hand, stool tests embrace various techniques, notably the fecal immunochemical test, guaiac-based fecal occult blood test, and multitarget stool DNA testing. In parallel, product segmentation brings to light the distinction between consumables and instruments. Here, consumables are considered through kits and reagents, while instruments are classified into CT scanners and endoscopes, integral components that underline the technical backbone of diagnostic procedures. Application-based segmentation further emphasizes the roles these tools play in disease monitoring, early detection, and prognosis assessment, reflecting the wide spectrum of clinical use-cases. Lastly, from an end user perspective, the market is segmented into ambulatory surgical centers, diagnostics laboratories, hospitals, and research institutes, each contributing uniquely to the continuum of patient care and scientific advancement.

Based on Type, market is studied across Screening Tests and Stool Tests. The Screening Tests is further studied across Blood Tests and Imaging Tests. The Imaging Tests is further studied across Colonoscopy, CT Colonography, and Flexible Sigmoidoscopy. The Stool Tests is further studied across Fecal Immunochemical Test, Guaiac-Based Fecal Occult Blood Test, and Multitarget Stool DNA Testing.

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Kits and Reagents. The Instruments is further studied across CT Scanners and Endoscopes.

Based on Application, market is studied across Disease Monitoring, Early Detection, and Prognosis Assessment.

Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostics Laboratories, Hospitals, and Research Institutes.

Strategic Regional Insights Across Key Global Markets

Analyzing the regional dynamics of the colorectal cancer screening and diagnostic market uncovers several compelling insights about global healthcare delivery that are deeply intertwined with varying economic, regulatory, and demographic factors. In the Americas, significant strides in healthcare infrastructure and government-led initiatives have resulted in rapid adoption of high-end diagnostic technologies, making early screening more accessible and efficient. Meanwhile, in the Europe, Middle East & Africa region, policy reforms and robust healthcare investments have fostered a competitive environment that encourages both public and private sector collaborations, driving innovation within the diagnostic sphere. In Asia-Pacific, the convergence of rising healthcare demands with increasing investments in research and technological infrastructure is opening new avenues for more personalized and accessible screening solutions. These geographic insights highlight not only the differential levels of market maturity but also the tailored approaches that governments and healthcare providers are embracing to combat colorectal cancer. Novel regional strategies and adaptation of best practices are proving critical as stakeholders seek to balance cost efficiency with technological excellence, ensuring that improved diagnostic accuracy and patient care transcend geographic boundaries.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Deep Dive into Major Key Companies in the Screening & Diagnostic Arena

Key players in the colorectal cancer screening and diagnostics market are driving the sector’s evolution through pioneering research, streamlined manufacturing approaches, and strategic collaborations. Major organizations, such as Abbott Laboratories, AbbVie Inc., and Agilent Technologies, Inc., have played an instrumental role in advancing diagnostic technology by investing in state-of-the-art imaging and testing protocols. Titan organizations like Bayer AG, Becton, Dickinson and Company, and Bio-Rad Laboratories, Inc. have been at the forefront of integrating advanced analytics with diagnostic applications, further strengthening market confidence. Other industry leaders, including bioMérieux SA, Bristol-Myers Squibb Company, and Clinical Genomics Technologies Pty Ltd., have contributed significantly by merging clinical expertise with technological breakthroughs. Companies such as Eiken Chemical Co., Ltd., Epigenomics AG, and Exact Sciences Corp. have further underscored the industry’s commitment to early detection through novel stool and blood test methodologies. Global entities like F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., and Medtronic PLC, continue to redefine the standards by developing reliable instruments that enhance diagnostic accuracy. Complementing this lineup, organizations including Guardant Health, Inc., Hologic, Inc., Illumina, Inc., and KARL STORZ SE & Co. KG, along with Merck KGaA, Myriad Genetics, Inc., Novartis AG, Novigenix SA, and Olympus Corporation, have also contributed their technological profundity. Additionally, Prenetics Global Limited, QIAGEN N.V., Quest Diagnostics Incorporated, Sanofi SA, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc. bolster the industry's capacity to innovate and adapt to rapidly changing market needs.

The report delves into recent significant developments in the Colorectal Cancer Screening & Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Bristol-Myers Squibb Company, Clinical Genomics Technologies Pty Ltd., Eiken Chemical Co., Ltd., Epigenomics AG, Exact Sciences Corp., F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Guardant Health, Inc., Hologic, Inc., Illumina, Inc., KARL STORZ SE & Co. KG, Medtronic PLC, Merck KGaA, Myriad Genetics, Inc., Novartis AG, Novigenix SA, Olympus Corporation, Prenetics Global Limited, QIAGEN N.V., Quest Diagnostics Incorporated, Sanofi SA, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific Inc..

Actionable Recommendations for Industry Leaders in Colorectal Cancer Diagnostics

Industry leaders in the colorectal cancer screening and diagnostic market are encouraged to leverage current technological advancements and flexible market strategies to enhance competitive positioning and long-term growth. A series of actionable recommendations include the continuous investment in research and development to foster innovation in both diagnostic tools and screening methodologies. Stakeholders should aim to diversify product lines by enhancing both consumable and instrument segments, ensuring that cutting-edge kits, reagents, CT scanners, and endoscopes are incorporated into comprehensive diagnostic solutions. Collaborative engagements across diagnostics laboratories, hospitals, ambulatory surgical centers, and research institutes should be intensified to promote integrated care models and more precise disease monitoring. Moreover, it is imperative to utilize data-driven insights to optimize market segmentation and inform strategic decisions tailored to regional healthcare dynamics. Investment in digital health infrastructure, augmented reality training, and telehealth platforms is also crucial to meet the evolving demands of a digital-first era. By embracing these recommendations, industry leaders can fortify their market foothold, drive innovation, and ultimately contribute to improved patient outcomes in the fight against colorectal cancer.

Summative Conclusion on the Future of Colorectal Cancer Screening and Diagnostics

In summation, the current colorectal cancer screening and diagnostic landscape is marked by rapid advancements, diversified segmentation, and a competitive dynamic continuously shaped by innovation. The integration of advanced imaging techniques, next-generation screening tests, and comprehensive product portfolios underscores the commitment across the sector to provide earlier, less invasive, and more accurate diagnostic options. Regional variations highlight the need for tailored strategies, as stakeholders across the Americas, Europe, Middle East & Africa, and Asia-Pacific adapt their approaches to align with local healthcare demands. Likewise, the active participation of global key players has been instrumental in pushing the boundaries of diagnostic technology and setting new benchmarks for quality and efficiency. As the market continues to evolve, it is the collective efforts of industry leaders, innovators, and decision-makers that stand to redefine screening paradigms and enhance clinical outcomes. The robust framework supporting early detection and monitoring paves the way for sustainable growth and significant public health benefits, driving the industry forward into an era characterized by precision and integrated care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of colorectal cancer cases worldwide
5.1.1.2. Growing emphasis on preventive healthcare and early detection among patients
5.1.1.3. Government initiatives and funding support for national cancer screening programs and guidelines
5.1.2. Restraints
5.1.2.1. Psychological discomfort and stigma associated with colorectal cancer screening procedures
5.1.3. Opportunities
5.1.3.1. Surge in investments in digital health tools worldwide
5.1.3.2. Integration of artificial intelligence for enhanced accuracy in colorectal cancer diagnosis
5.1.4. Challenges
5.1.4.1. Delayed regulatory approval procedures for colorectal cancer screening tools
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing preference for imaging tests due to its dual diagnostic and therapeutic capability
5.2.2. Application: Expanding application of colorectal cancer screening and diagnostics for early cancer detection
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Colorectal Cancer Screening & Diagnostic Market, by Type
6.1. Introduction
6.2. Screening Tests
6.2.1. Blood Tests
6.2.2. Imaging Tests
6.2.2.1. Colonoscopy
6.2.2.2. CT Colonography
6.2.2.3. Flexible Sigmoidoscopy
6.3. Stool Tests
6.3.1. Fecal Immunochemical Test
6.3.2. Guaiac-Based Fecal Occult Blood Test
6.3.3. Multitarget Stool DNA Testing
7. Colorectal Cancer Screening & Diagnostic Market, by Product
7.1. Introduction
7.2. Consumables
7.2.1. Kits
7.2.2. Reagents
7.3. Instruments
7.3.1. CT Scanners
7.3.2. Endoscopes
8. Colorectal Cancer Screening & Diagnostic Market, by Application
8.1. Introduction
8.2. Disease Monitoring
8.3. Early Detection
8.4. Prognosis Assessment
9. Colorectal Cancer Screening & Diagnostic Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostics Laboratories
9.4. Hospitals
9.5. Research Institutes
10. Americas Colorectal Cancer Screening & Diagnostic Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Colorectal Cancer Screening & Diagnostic Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Colorectal Cancer Screening & Diagnostic Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Scenario Analysis
13.3.1. ColoWatch and Bracco Diagnostics partner to expand the availability of virtual colonoscopy for the early detection of colon and rectal cancer
13.3.2. Owkin and Roche collaborate on MSIntuit CRC v2 to enhance colorectal cancer diagnosis through AI advancements
13.3.3. FDA approval of Cologuard Plus enhances colorectal cancer screening with improved sensitivity and specificity
13.3.4. FDA approval of Guardant Shield blood test enhances colorectal cancer screening with non-invasive option
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET MULTI-CURRENCY
FIGURE 2. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET MULTI-LANGUAGE
FIGURE 3. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET RESEARCH PROCESS
FIGURE 4. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 13. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 15. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 17. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 19. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 25. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET DYNAMICS
TABLE 7. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CT COLONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY FLEXIBLE SIGMOIDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY FECAL IMMUNOCHEMICAL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY GUAIAC-BASED FECAL OCCULT BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY MULTITARGET STOOL DNA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PROGNOSIS ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 69. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 70. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 71. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 73. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 80. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 82. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 116. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 117. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 118. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 120. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 121. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. CHINA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 125. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 126. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 127. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 129. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 130. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. INDIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 134. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 135. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 143. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 144. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 145. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 147. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 171. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 179. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 188. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 189. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 197. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 198. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 199. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 201. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 202. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. THAILAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 206. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 207. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 223. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 225. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 227. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 229. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 234. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 235. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 236. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 238. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 239. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 245. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 247. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 248. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 252. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 254. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 256. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 261. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 262. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 263. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 265. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 266. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. GERMANY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 279. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 280. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY STOOL TESTS, 2018-2030 (USD MILLION)
TABLE 281. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 283. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 284. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. ITALY COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY SCREENING TESTS, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS COLORECTAL CANCER SCREENING & DIAGNOSTIC MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS COLOR

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bristol-Myers Squibb Company
  • Clinical Genomics Technologies Pty Ltd.
  • Eiken Chemical Co., Ltd.
  • Epigenomics AG
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic PLC
  • Merck KGaA
  • Myriad Genetics, Inc.
  • Novartis AG
  • Novigenix SA
  • Olympus Corporation
  • Prenetics Global Limited
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Sanofi SA
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMarch 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.86 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Colorectal Cancer Screening Market Report 2024 - Product Image

Colorectal Cancer Screening Market Report 2024

  • Report
  • 175 Pages
  • Global
From
EUR$4,000USDGBP
Colorectal Cancer Screening and Diagnostics Market - Product Image

Colorectal Cancer Screening and Diagnostics Market

  • Report
  • 166 Pages
  • Global
From
EUR$4,650USDGBP
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 159 Pages
  • Global
From
EUR$4,000USDGBP
Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - Product Image

Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

  • Report
  • Global
From
EUR$7,500USDGBP
Breast Cancer Screening Market by Technology, Product, End User - Global Forecast 2025-2030 - Product Image

Breast Cancer Screening Market by Technology, Product, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Copyright © 2002-2025 Research and Markets. All Rights Reserved.